Dahiya Anita, Wiebe Natasha, Harrison Tyrone G, James Matthew T, Pannu Neesh
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Kidney Med. 2025 May 16;7(7):101029. doi: 10.1016/j.xkme.2025.101029. eCollection 2025 Jul.
RATIONALE & OBJECTIVE: Studies have reported an increase in acute kidney injury (AKI) incidence; however, they are limited by administrative codes. We aimed to identify trends in AKI incidence, severity, and mortality using Kidney Disease: Improving Global Outcomes (KDIGO)-based definitions.
This is a retrospective, population-based cohort study.
SETTING & POPULATION: Hospitalized adult patients in Alberta, Canada from 2009-2018.
AKI episodes were identified using validated KDIGO definitions.
We assessed in-hospital and 90-day all-cause mortality.
Generalized linear models with a Gaussian family were used to determine absolute rates of AKI and mortality. Rates of AKI and mortality were adjusted for patient demographics and comorbid conditions.
There were 339,986 hospitalizations with an episode of AKI (12.7%, 2,668,954 hospitalizations) with a median age of 70 years (56, 82) and 152,115 (44.7%) women. AKI rates increased by an unadjusted relative increase of 5.5% (95% confidence interval [CI], 4.2-6.9). When fully adjusted, a relative decrease of 11.2% (95% CI, 9.2-13.2) was seen in rates of AKI. Stage 1 AKI was most common (unadjusted mean rate, 659 per 100,000 person-years [95% CI, 655-662]). In-hospital mortality decreased across all stages of AKI with the greatest decrease noted in stage 3 AKI requiring kidney replacement therapy (unadjusted relative decrease 29.9% [95% CI, 20-38.6]). Similar trends were identified in 90-day mortality.
The primary strength of this paper is that it involves a large cohort of patients from a diverse population. The use of KDIGO definition of AKI is limited by the reliance on serum creatinine values.
Although rates of AKI appear to be increasing, this seems to be largely driven by patient comorbid condition with the highest rates seen in stage 1 AKI. Furthermore, there was an overall increase in rates of AKI in patients aged younger than 60 and a decrease in the most elderly of patients in both the crude and adjusted data, suggesting potential changes in practice patterns and patient characteristics. Despite this increase, there was an overall decrease in mortality, especially in severe forms of AKI.
研究报告了急性肾损伤(AKI)发病率的上升;然而,这些研究受限于行政编码。我们旨在使用基于改善全球肾脏病预后(KDIGO)的定义来确定AKI发病率、严重程度和死亡率的趋势。
这是一项基于人群的回顾性队列研究。
2009年至2018年加拿大艾伯塔省的住院成年患者。
使用经过验证的KDIGO定义识别AKI发作。
我们评估了住院期间和90天的全因死亡率。
使用高斯族广义线性模型来确定AKI和死亡率的绝对发生率。对AKI和死亡率进行了患者人口统计学和合并症的调整。
共有339,986例住院患者发生AKI发作(占住院总数的12.7%,共2,668,954例住院),中位年龄为70岁(56, 82),女性152,115例(44.7%)。未经调整的AKI发生率相对增加了5.5%(95%置信区间[CI],4.2 - 6.9)。在进行完全调整后,AKI发生率相对下降了11.2%(95% CI,9.2 - 13.2)。1期AKI最为常见(未经调整的平均发生率为每100,000人年659例[95% CI,655 - 662])。在所有AKI阶段,住院死亡率均有所下降,其中需要肾脏替代治疗的3期AKI下降最为明显(未经调整的相对下降29.9%[95% CI,20 - 38.6])。90天死亡率也呈现类似趋势。
本文的主要优势在于纳入了来自不同人群的大量患者队列。使用KDIGO对AKI的定义受到对血清肌酐值依赖的限制。
尽管AKI的发生率似乎在上升,但这在很大程度上似乎是由患者的合并症驱动的,1期AKI的发生率最高。此外,在60岁以下患者中,AKI发生率总体上升,而在最年长患者中,无论是粗数据还是调整后的数据中AKI发生率均下降,这表明实践模式和患者特征可能发生了变化。尽管发生率有所上升,但死亡率总体下降,尤其是在严重形式的AKI中。